The Effects of Dexmedetomidine and Tracheal Intubation on Heart Rate Variability and QTc Interval

Trial Profile

The Effects of Dexmedetomidine and Tracheal Intubation on Heart Rate Variability and QTc Interval

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Pain
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Dec 2013 Planned number of patients changed from 60 to 66 as reported by ClinicalTrials.gov.
    • 04 Dec 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 04 Dec 2013 Status changed from completed to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top